Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127155181 | 12715518 | 1 | I | 20160901 | 20160906 | 20160906 | EXP | CA-ROCHE-1825185 | ROCHE | 0.00 | A | F | Y | 0.00000 | 20160906 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127155181 | 12715518 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | U | 125276 | ||||||||||
| 127155181 | 12715518 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | ON HOLD | 0 | 5 | MG | BID | |||||||
| 127155181 | 12715518 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 0 | |||||||||||
| 127155181 | 12715518 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | |||||||||||
| 127155181 | 12715518 | 5 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 0 | |||||||||||
| 127155181 | 12715518 | 6 | C | REACTINE (CANADA) | CETIRIZINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127155181 | 12715518 | 1 | Product used for unknown indication |
| 127155181 | 12715518 | 2 | Rheumatoid arthritis |
| 127155181 | 12715518 | 3 | Rheumatoid arthritis |
| 127155181 | 12715518 | 4 | Rheumatoid arthritis |
| 127155181 | 12715518 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127155181 | 12715518 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127155181 | 12715518 | Dizziness | |
| 127155181 | 12715518 | Drug effect decreased | |
| 127155181 | 12715518 | Drug hypersensitivity | |
| 127155181 | 12715518 | Dyspnoea | |
| 127155181 | 12715518 | Fatigue | |
| 127155181 | 12715518 | Pericarditis | |
| 127155181 | 12715518 | Rash | |
| 127155181 | 12715518 | Swelling | |
| 127155181 | 12715518 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127155181 | 12715518 | 2 | 20151117 | 20160815 | 0 |